Sasco Capital Inc. CT grew its holdings in MEDNAX, Inc. (NYSE:MD – Get Rating) by 349.7% in the fourth quarter, Holdings Channel reports. The firm owned 41,910 shares of the company’s stock after buying an additional 32,590 shares during the quarter. Sasco Capital Inc. CT’s holdings in MEDNAX were worth $1,140,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Maryland State Retirement & Pension System grew its holdings in shares of MEDNAX by 1.5% in the fourth quarter. Maryland State Retirement & Pension System now owns 34,465 shares of the company’s stock worth $938,000 after acquiring an additional 506 shares during the period. Profund Advisors LLC grew its holdings in shares of MEDNAX by 8.2% in the fourth quarter. Profund Advisors LLC now owns 9,308 shares of the company’s stock worth $253,000 after acquiring an additional 706 shares during the period. M&T Bank Corp lifted its position in MEDNAX by 4.7% during the fourth quarter. M&T Bank Corp now owns 16,569 shares of the company’s stock valued at $451,000 after purchasing an additional 739 shares in the last quarter. Victory Capital Management Inc. lifted its position in MEDNAX by 2.5% during the fourth quarter. Victory Capital Management Inc. now owns 32,865 shares of the company’s stock valued at $894,000 after purchasing an additional 807 shares in the last quarter. Finally, O Shaughnessy Asset Management LLC lifted its position in MEDNAX by 5,380.0% during the third quarter. O Shaughnessy Asset Management LLC now owns 1,096 shares of the company’s stock valued at $31,000 after purchasing an additional 1,076 shares in the last quarter. 95.68% of the stock is owned by institutional investors.
Shares of NYSE MD traded up $0.12 during trading hours on Tuesday, reaching $18.42. The stock had a trading volume of 5,698 shares, compared to its average volume of 495,720. The company has a current ratio of 1.63, a quick ratio of 1.63 and a debt-to-equity ratio of 0.92. The firm has a market cap of $1.61 billion, a price-to-earnings ratio of 17.10, a P/E/G ratio of 1.15 and a beta of 2.05. The business’s fifty day moving average price is $22.65 and its two-hundred day moving average price is $24.79. MEDNAX, Inc. has a 52-week low of $18.15 and a 52-week high of $35.67.
Several brokerages have recently issued reports on MD. Credit Suisse Group reduced their target price on MEDNAX from $32.00 to $31.00 and set an “outperform” rating on the stock in a report on Wednesday, February 23rd. TheStreet cut MEDNAX from a “b-” rating to a “c+” rating in a research note on Wednesday, April 13th. Mizuho reduced their price objective on MEDNAX from $28.00 to $23.00 in a research note on Monday, May 2nd. Deutsche Bank Aktiengesellschaft reduced their price objective on MEDNAX from $24.00 to $16.00 in a research note on Tuesday. Finally, StockNews.com cut MEDNAX from a “buy” rating to a “hold” rating in a research note on Monday, May 2nd. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and one has given a buy rating to the company. Based on data from MarketBeat.com, MEDNAX presently has an average rating of “Hold” and an average price target of $27.25.
MEDNAX Company Profile (Get Rating)
MEDNAX, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.
- Get a free copy of the StockNews.com research report on MEDNAX (MD)
- High-Yield Deep-Value LCI Industries Exceeds All Expectations
- Shopify (NYSE: SHOP) Approaches Key Support Level
- Intuitive Surgical is an Intuitive Buy
- Follow The Money To Cigna
- The Low In Lordstown Motors May Not Be The Last
Receive News & Ratings for MEDNAX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MEDNAX and related companies with MarketBeat.com's FREE daily email newsletter.